Doctors Note Logo

Published on: 9/16/2026

Could alopecia areata spread to all my hair or is it a sign of another disease?

Alopecia areata can sometimes progress beyond patchy hair loss to affect the entire scalp (alopecia totalis) or all body hair (alopecia universalis), though most people experience limited patches that may regrow, and the risk depends on factors like age at onset, extent of loss, nail changes, and family history. Because it is an autoimmune condition, it can also occur alongside thyroid disease, vitiligo, atopic dermatitis, type 1 diabetes, or anemia, so widespread or unusual shedding sometimes points to another underlying issue worth evaluating. Other causes of diffuse hair loss, including telogen effluvium, scarring alopecias, and nutritional deficiencies, can mimic or overlap with it. There are several important details that influence whether your hair loss is likely to spread and which tests may be needed, so see below to understand more.

Since patterns of hair loss can look similar but require very different treatment, and because early intervention often gives the best chance of regrowth, it helps to get an organized picture of your symptoms before your next appointment. A free, instant, online symptom check can help you sort out which clues in your own case matter most, what conditions may be worth ruling out, and which type of clinician to see next.

Last reviewed for medical accuracy: 09/15/2026

answer background

Explanation

Could Alopecia Areata Spread to All My Hair or Is It a Sign of Another Disease?

Alopecia areata is a common autoimmune condition that causes patchy hair loss. It affects up to 2% of people at some point in their lives. If you’ve noticed one or more bald spots, it’s natural to worry whether those patches might spread to cover your entire scalp—or even your body—and whether there’s a more serious underlying disease.

Below, you’ll find clear, evidence-based information about:

  • How alopecia areata behaves
  • Possible patterns of spread
  • Links to other health conditions
  • When to seek further evaluation
  • Treatment and management strategies

What Is Alopecia Areata?

Alopecia areata occurs when your immune system mistakenly attacks hair follicles, causing them to enter a resting phase. Hair shafts then fall out, typically in small, round patches. In most cases:

  • The scalp is affected, although eyebrows, eyelashes, beard area, and body hair can also be involved.
  • Patches may heal on their own as hair regrows.
  • New patches can appear months or years after the first episode.

Key points:

  • It is not contagious.
  • It is not caused by poor hygiene, stress alone, or nutritional deficiencies—although stress or other triggers can play a role.
  • It is an autoimmune condition, meaning your body’s defense system targets its own tissues.

Can Alopecia Areata Spread to All of My Hair?

Yes, alopecia areata can progress in severity but in variable ways:

  1. Patchy Alopecia Areata

    • The most common form.
    • A few discrete bald spots appear on the scalp or elsewhere.
    • Patches may come and go.
  2. Alopecia Totalis

    • Total loss of scalp hair.
    • Occurs in up to 10–15% of people with alopecia areata.
  3. Alopecia Universalis

    • Complete loss of all body hair (scalp, eyebrows, eyelashes, arms, legs, etc.).
    • Occurs in about 7–10% of cases.

Progression is unpredictable:

  • Some people experience only a single episode of patchy hair loss and complete regrowth.
  • Others may cycle through several episodes of patchy loss and regrowth.
  • A smaller group progresses to totalis or universalis, but many of these too will see some regrowth over time.

Bottom line:
While any progression can feel alarming, severe forms remain relatively uncommon. Regular follow-up with a dermatologist helps monitor changes and adapt treatment early.


Is It a Sign of Another Disease?

Alopecia areata itself is a distinct autoimmune condition. However, it can coexist with other autoimmune disorders in some individuals. Having alopecia areata does not necessarily mean you have—or will develop—another disease, but you may have a slightly higher risk of:

  • Thyroid disorders (Hashimoto’s thyroiditis or Graves’ disease)
  • Vitiligo (loss of skin pigment in patches)
  • Rheumatoid arthritis
  • Type 1 diabetes
  • Inflammatory bowel disease (Crohn’s disease or ulcerative colitis)
  • Lupus erythematosus

When to consider further evaluation:

  • You experience symptoms beyond hair loss, such as fatigue, weight changes, joint pain, digestive issues, or skin depigmentation.
  • You have a personal or family history of autoimmune conditions.

When to Seek Additional Medical Advice

Even though most cases of alopecia areata follow a benign course, certain signs warrant a prompt check-in with your healthcare provider:

  • Rapid spread from a few patches to full scalp involvement.
  • Sudden onset of other unexplained symptoms (fever, joint swelling, digestive upset).
  • Emotional distress or difficulty coping with hair loss.
  • Concerns about other autoimmune conditions in yourself or your family.

You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify whether you need to pursue lab tests or specialist referrals.


Diagnosis

A dermatologist will typically diagnose alopecia areata based on:

  • Clinical appearance (smooth, round patches).
  • Family history of autoimmunity.
  • Gentle scalp examination.
  • In some cases, a scalp biopsy or blood tests to rule out other causes (e.g., fungal infection, nutritional deficiencies, thyroid function).

Treatment Options

There’s no one-size-fits-all cure, but several treatments can help stimulate hair regrowth and limit new loss. Your dermatologist will tailor therapy to the extent of your disease, age, and personal preferences. Common approaches:

  • Topical Corticosteroids
    Applied directly to patches to reduce inflammation.

  • Intralesional Corticosteroid Injections
    Small steroid injections into each bald patch, often effective for limited disease.

  • Topical Immunotherapy
    Applying agents (e.g., diphenylcyclopropenone) to provoke a mild allergic reaction that distracts the immune system.

  • Minoxidil (Rogaine®)
    A topical medication that can stimulate hair follicles.

  • Oral Treatments
    In more extensive disease, low-dose corticosteroids or medications that suppress the immune system.

  • Janus Kinase (JAK) Inhibitors
    Newer oral drugs (e.g., tofacitinib, ruxolitinib) showing promising results for severe cases. These require careful monitoring for side effects.

  • Supportive Options
    Wigs, scarves, cosmetic camouflage, eyebrow microblading, and counseling for emotional support.


Coping and Prognosis

  • Hair regrowth often occurs within 6–12 months in patchy cases.
  • Even in totalis or universalis, regrowth is possible, though it may be slower and incomplete.
  • Relapses are common; some people cycle through loss and regrowth for years.

Strategies to feel more in control:

  • Join patient support groups or online communities.
  • Practice stress-management techniques (mindfulness, yoga, therapy).
  • Explore adaptive cosmetics or head coverings for confidence.
  • Keep regular appointments with your dermatologist to reassess treatment.

Key Takeaways

  • Alopecia areata is an autoimmune condition that causes patchy hair loss and, less frequently, total scalp or body hair loss.
  • Progression to alopecia totalis or universalis occurs in a minority of cases.
  • It can be associated with other autoimmune disorders but does not, by itself, always signal a hidden disease.
  • Early diagnosis and tailored treatment can improve outcomes.
  • Monitoring by a healthcare professional is essential if you notice rapid changes or other systemic symptoms.

If you’re ever unsure about your symptoms or worried about other health issues, speak with your doctor. For a quick preliminary evaluation, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a convenient way to gather information before your appointment.


Important: This information is intended to be comprehensive yet accessible. It does not replace medical advice. If you experience life-threatening symptoms or severe emotional distress, please seek immediate medical attention. Always speak to your doctor about any serious or persistent health concerns.

(References)

  • * Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141. PMID: 29241771.

  • * Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. J Am Acad Dermatol. 2020 Mar;82(3):675-682. doi: 10.1016/j.jaad.2019.08.032. Epub 2019 Aug 19. PMID: 31437543.

  • * Conic RZ, Tamashunas NL, Damiani G, Fabbrocini G, Cantelli M, Young Dermatologists Italian Network, Bergfeld WF. Comorbidities in pediatric alopecia areata. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2898-2901. doi: 10.1111/jdv.16727. Epub 2020 Aug 6. PMID: 32531131.

  • * Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review. J Am Acad Dermatol. 2021 Jul;85(1):162-175. doi: 10.1016/j.jaad.2020.06.047. Epub 2020 Jun 17. PMID: 32561373; PMCID: PMC8260215.

  • * Sterkens A, Lambert J, Bervoets A. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options. Clin Exp Med. 2021 May;21(2):215-230. doi: 10.1007/s10238-020-00673-w. Epub 2021 Jan 1. PMID: 33386567.

  • * Zhou C, Li X, Wang C, Zhang J. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management. Clin Rev Allergy Immunol. 2021 Dec;61(3):403-423. doi: 10.1007/s12016-021-08883-0. Epub 2021 Aug 17. PMID: 34403083.

  • * King BA, Craiglow BG. Janus kinase inhibitors for alopecia areata. J Am Acad Dermatol. 2023 Aug;89(2S):S29-S32. doi: 10.1016/j.jaad.2023.05.049. PMID: 37591562.

  • * Dainichi T, Iwata M, Kaku Y. Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis? J Dermatol Sci. 2023 Dec;112(3):120-127. doi: 10.1016/j.jdermsci.2023.09.008. Epub 2023 Oct 11. PMID: 37833164.

  • * Rudnicka L, Arenbergerova M, Grimalt R, Ioannides D, Katoulis AC, Lazaridou E, Olszewska M, Ovcharenko YS, Piraccini BM, Prohic A, Rakowska A, Reygagne P, Richard MA, Soares RO, Starace M, Vañó-Galvan S, Waskiel-Burnat A. European expert consensus statement on the systemic treatment of alopecia areata. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):687-694. doi: 10.1111/jdv.19768. Epub 2024 Jan 2. PMID: 38169088.

  • * Kalil L, Welch D, Heath CR, Craiglow BG. Systemic Therapies for Pediatric Alopecia Areata. Pediatr Dermatol. 2025 Mar;42 Suppl 1:36-42. doi: 10.1111/pde.15822. PMID: 40044621.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.